“Mostly positive”: respiratory physician welcomes PBS review of COPD therapies

A PBS review of COPD therapies has recommended a mix of prescribing restrictions to encourage spirometry and easing of criteria for starting some combination inhalers. The final report from the Post-market Review of Chronic Obstructive Pulmonary Disease (COPD) Medicines was released on 30 January, comprising 11 recommendations. As previously reported in the limbic, it includes ...

Already a member?

Login to keep reading.

© 2021 the limbic